ACE-2, TMPRSS2 and Beyond; Promising Targets and Tools for COVID-19 Prophylaxis and Treatment
Several repurposing drugs and ongoing vaccine researches to combat Coronavirus Disease-19 (COVID-19) are testing clinically, worldwide. COVID-19 caused by severe acute respiratory failure syndrome-CoV-2, uses angiotensin-converting enzyme 2 (ACE-2) as a functional receptor for entry into the cells,...
Main Authors: | Akçahan GEPDİREMEN, Meltem KUMAŞ |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2020-12-01
|
Series: | Bezmiâlem Science |
Subjects: | |
Online Access: |
http://bezmialemscience.org/archives/archive-detail/article-preview/ace-2-tmprss2-and-beyond-promising-targets-and-too/42777
|
Similar Items
-
Expression of SARS-CoV-2 receptor ACE2 and the protease TMPRSS2 suggests susceptibility of the human embryo in the first trimester
by: Bailey A. T. Weatherbee, et al.
Published: (2020-08-01) -
ACE2 and TMPRSS2 Immunolocalization and COVID-19-Related Thyroid Disorder
by: Gi-Cheol Park, et al.
Published: (2022-04-01) -
Commentary: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
by: Alexandra Lindsey Zune Djomkam, et al.
Published: (2020-08-01) -
ACE2 and TMPRSS2 expression in patients before, during, and after SARS-CoV-2 infection
by: Henrique Borges da Silva Grisard, et al.
Published: (2024-03-01) -
Expression Pattern of the SARS-CoV-2 Entry Genes <i>ACE2</i> and <i>TMPRSS2</i> in the Respiratory Tract
by: Yichuan Liu, et al.
Published: (2020-10-01)